LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026
NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced that the Company has rescheduled its third quarter 2026 earnings release and conference call to Thursday, November 12, 2026.
LifeMD expects to issue its third quarter 2026 earnings press release on or around 4:05 p.m. Eastern time on Thursday, November 12, 2026 followed by the conference call at 4:30 p.m. Eastern time. Information for the rescheduled conference call is as follows:
Conference Call & Webcast Details
| Date: | Thursday, November 12th |
| Time: | 4:30 p.m. Eastern time |
| Toll-Free Dial-In: | (877) 270-2148 |
| International Dial-In: | +1 (412) 902-6510 |
| Conference ID: | LifeMD, Inc. Third Quarter 2026 Results |
| Live & Archived Webcast: | Link |
About LifeMD, Inc.
LifeMD® is a leading virtual care company making high-quality healthcare more accessible, convenient, and affordable. Through its vertically integrated platform, LifeMD connects patients with a 50-state affiliated medical group, laboratory services, a state-of-the-art nationwide pharmacy with home delivery, and a U.S.-based patient care center. Together, these capabilities support care across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. For more information, please visit LifeMD.com.
Investor Contact
ir@lifemd.com
Media Contact
press@lifemd.com
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
3 of the Best Dividend Stocks to Own
The 10 Best Companies to Invest in Now
These Overvalued Stocks Have Plenty of Room to Fall
United States